The Role of Amylin in Bone Metabolism

Clinical trial NCT06186063 · UNKNOWN

Trial details

NCT number: NCT06186063
Sponsor: Filip Krag Knop
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Bone Diseases, Metabolic Type 1 Diabetes

Start date: 2024-02-12
Primary completion: 2024-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.